| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999782 | Urologic Oncology: Seminars and Original Investigations | 2015 | 8 Pages |
Abstract
The present results suggest that the mouse urothelium produces mBD2 in response to intravesicular BCG as a defense mechanism against BCG, and blocking mBD2 by an anti-mBD2 antibody increased the effectiveness of BCG.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jong Kyou M.D., Byung Hoon M.D., Se Young M.D., Soon-Ja Kim, Tae-Jin M.D., Kijeong M.D., In Ho M.D.,